CN116236408A - Whitening composition derived from three traditional Chinese medicine active ingredients and application thereof - Google Patents
Whitening composition derived from three traditional Chinese medicine active ingredients and application thereof Download PDFInfo
- Publication number
- CN116236408A CN116236408A CN202310317833.XA CN202310317833A CN116236408A CN 116236408 A CN116236408 A CN 116236408A CN 202310317833 A CN202310317833 A CN 202310317833A CN 116236408 A CN116236408 A CN 116236408A
- Authority
- CN
- China
- Prior art keywords
- traditional chinese
- active ingredients
- chinese medicine
- whitening composition
- composition derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 64
- 239000003814 drug Substances 0.000 title claims abstract description 58
- 239000004480 active ingredient Substances 0.000 title claims abstract description 55
- 239000000203 mixture Substances 0.000 title claims abstract description 52
- ZPIKVDODKLJKIN-NSHDSACASA-N Senkyunolide Chemical compound C1CC=CC2=C1[C@H](CCCC)OC2=O ZPIKVDODKLJKIN-NSHDSACASA-N 0.000 claims abstract description 40
- VLEUZFDZJKSGMX-UHFFFAOYSA-N pterostilbene Natural products COC1=CC(OC)=CC(C=CC=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-UHFFFAOYSA-N 0.000 claims abstract description 20
- VLEUZFDZJKSGMX-ONEGZZNKSA-N pterostilbene Chemical compound COC1=CC(OC)=CC(\C=C\C=2C=CC(O)=CC=2)=C1 VLEUZFDZJKSGMX-ONEGZZNKSA-N 0.000 claims abstract description 20
- INJOMKTZOLKMBF-UHFFFAOYSA-N Guanfacine Chemical compound NC(=N)NC(=O)CC1=C(Cl)C=CC=C1Cl INJOMKTZOLKMBF-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000002537 cosmetic Substances 0.000 claims abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 6
- 201000010099 disease Diseases 0.000 claims abstract description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 7
- 208000003351 Melanosis Diseases 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 208000037259 Amyloid Plaque Diseases 0.000 claims description 3
- 206010008570 Chloasma Diseases 0.000 claims description 3
- 206010027145 Melanocytic naevus Diseases 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 208000007256 Nevus Diseases 0.000 claims description 3
- 206010042496 Sunburn Diseases 0.000 claims description 3
- 201000001441 melanoma Diseases 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 3
- 208000017520 skin disease Diseases 0.000 claims description 3
- 208000035475 disorder Diseases 0.000 claims 1
- 230000000215 hyperchromic effect Effects 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract description 40
- 230000000694 effects Effects 0.000 abstract description 37
- 102000003425 Tyrosinase Human genes 0.000 abstract description 21
- 108060008724 Tyrosinase Proteins 0.000 abstract description 21
- 230000002401 inhibitory effect Effects 0.000 abstract description 13
- 230000002000 scavenging effect Effects 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 9
- 210000002780 melanosome Anatomy 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 239000000049 pigment Substances 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 15
- 241000252212 Danio rerio Species 0.000 description 12
- 230000005764 inhibitory process Effects 0.000 description 11
- 230000003061 melanogenesis Effects 0.000 description 9
- 210000002752 melanocyte Anatomy 0.000 description 8
- 210000001161 mammalian embryo Anatomy 0.000 description 6
- 238000012258 culturing Methods 0.000 description 4
- 238000011081 inoculation Methods 0.000 description 4
- 230000008099 melanin synthesis Effects 0.000 description 4
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- 208000012641 Pigmentation disease Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 238000012925 biological evaluation Methods 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000008976 Pterocarpus marsupium Species 0.000 description 1
- 235000010453 Pterocarpus marsupium Nutrition 0.000 description 1
- 241000750718 Pterocarpus santalinus Species 0.000 description 1
- 244000235659 Rubus idaeus Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000013178 mathematical model Methods 0.000 description 1
- 210000003574 melanophore Anatomy 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- -1 pterostilbene Chemical compound 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 235000021013 raspberries Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a whitening composition derived from three traditional Chinese medicine active ingredients, which consists of 24-82 parts of raspberry ketone glucoside, 16-41 parts of pterostilbene and 11-36 parts of senkyunolide A, wherein the whitening composition derived from the three traditional Chinese medicine active ingredients has good whitening effect by inhibiting tyrosinase activity, reducing tyrosinase expression level, scavenging free radicals, scavenging NO, inhibiting multi-dimensionality such as melanosome transportation and inhibiting melanin formation in multiple paths by utilizing the three effective ingredients derived from the natural traditional Chinese medicines, and has high market popularization value. The invention also discloses application of the whitening composition derived from the three traditional Chinese medicine active ingredients in preparation of medicines or cosmetics for treating and/or preventing the pigment increase diseases.
Description
Technical Field
The invention relates to a whitening composition derived from three traditional Chinese medicine active ingredients and application thereof.
Background
Under normal physiological conditions, melanin can protect human skin from ultraviolet rays, toxic chemicals, other environmental factors, and the like. However, excessive production and abnormal accumulation of melanin can cause pigment-increasing diseases such as freckle, chloasma, senile plaque, cyasma, coffee spot, sunburn, nevus, melanoma and other pigment-increasing skin diseases, seriously affect the appearance of patients, and cause great mental stress to the patients. Skin pigmentation is closely related to melanin production, tyrosinase is the rate-limiting enzyme for melanin production, and inhibition of tyrosinase production or tyrosinase activity is effective in inhibiting melanin production. It has been found that oxidative stress generated by free radicals during melanogenesis also promotes melanocyte production of melanin by activating a series of cell pathways; in addition, NO can increase melanin synthesis by melanocytes. Therefore, the antioxidant and the NO scavenger can synergistically enhance the whitening effect. Skin pigmentation is not only dependent on melanogenesis, but also is related to the distribution of melanin transport to keratinocytes, melanosomes are organelles of melanogenesis, storage and transport, and inhibition of melanosome transport is effective in exerting a whitening effect.
Disclosure of Invention
The invention aims to overcome the defects of the prior art, provides a whitening composition derived from three traditional Chinese medicine active ingredients and application thereof, utilizes the three active ingredients derived from natural traditional Chinese medicines, has good whitening effect by inhibiting tyrosinase activity, reducing tyrosinase expression level, scavenging free radicals, scavenging NO, inhibiting melanin formation by multiple dimensions and multiple paths such as melanosome transportation and the like, determines the optimal compatibility ratio of the three active ingredients for whitening effect, can be used in the fields of medicines and cosmetics, and has high market popularization value.
The technical scheme for achieving the purpose is as follows: a whitening composition derived from three traditional Chinese medicine active ingredients comprises, by weight, 24-82 parts of raspberry ketone glucoside, 16-41 parts of pterostilbene and 11-36 parts of senkyunolide A.
The whitening composition derived from the three traditional Chinese medicine active ingredients comprises the raspberry ketone glucoside, pterostilbene and senkyunolide A in a mass ratio of 0.54:0.25:0.21.
The whitening composition derived from the three traditional Chinese medicine active ingredients is prepared by chemical synthesis or natural animal and plant extraction and purification of raspberry ketone glucoside, pterostilbene and senkyunolide A.
The invention also provides application of the whitening composition derived from the three traditional Chinese medicine active ingredients in preparing medicines or cosmetics for treating and/or preventing the pigment increase diseases.
The application of the whitening composition derived from the three traditional Chinese medicine active ingredients, wherein the pigmentary diseases comprise freckles, chloasma, senile plaques, cyasma, coffee spots, sunburn, nevus and melanoma-associated skin diseases.
In the technical scheme of the whitening composition derived from three traditional Chinese medicine active ingredients and the application thereof, raspberry ketone glucoside (Raspberry ketone glucoside, RKG) is one of the effective ingredients of the traditional Chinese medicine raspberries, and has certain whitening, NO removal, antibacterial and other effects. Pterostilbene (Pterostilbene) is one of the effective components of the traditional Chinese medicine pterocarpus santalinus, also exists in plants such as blueberries, grapes and Pterocarpus marsupium, has the effects of resisting cancer, inflammation, oxidization and the like, has a certain whitening effect, and can effectively inhibit melanophore transport. The senkyunolide A (Senkyunolide A) is one of the effective components of the traditional Chinese medicine ligusticum wallichii, and has certain effects of whitening, antioxidation, pain relieving, antibiosis and the like.
According to the technical scheme of the whitening composition derived from three traditional Chinese medicine active ingredients and the application thereof, the three traditional Chinese medicine active ingredients are utilized, and the whitening composition derived from the three traditional Chinese medicine active ingredients can be used in the fields of medicines and cosmetics, and has high market popularization value by inhibiting tyrosinase activity, reducing tyrosinase expression level, scavenging free radicals, scavenging NO, inhibiting melanosome transportation and other multidimensional and multipath melanin formation, and has good whitening effect.
Drawings
FIG. 1 is a three-dimensional block diagram of a D-best design model construction;
fig. 2 is a graph showing the effect of whitening compositions derived from three traditional Chinese medicine active ingredients with different compatibility ratios on B16F10 cell melanogenesis;
FIG. 3 is a graph showing the effect of the whitening composition derived from three traditional Chinese medicine active ingredients with different compatibility ratios on B16F10 cell tyrosinase activity;
fig. 4 is a graph showing the effect of the whitening composition derived from three traditional Chinese medicine active ingredients with different compatibility ratios on the melanogenesis of zebra fish.
Detailed Description
In order to enable those skilled in the art to better understand the technical scheme of the present invention, the following detailed description is provided with reference to the accompanying drawings:
the whitening composition comprises, by weight, 24-82 parts of raspberry ketone glucoside, 16-41 parts of pterostilbene and 11-36 parts of senkyunolide A. The raspberry ketone glucoside, pterostilbene and senkyunolide A are prepared by chemical synthesis or natural animal and plant extraction and purification respectively. The raspberry ketone glucoside, pterostilbene and senkyunolide A can also be commercially available products.
The mass ratios of the raspberry ketone glucoside, pterostilbene and senkyunolide A in the whitening composition derived from the three traditional Chinese medicine active ingredients are shown in the following table:
table 1, different mass ratios between raspberry ketone glucoside, pterostilbene and senkyunolide a:
| name of the name | Mass |
| Compatibility proportion | |
| 1 | 0.4:0.3:0.3 |
| Compatibility ratio 2 | 0.98:0.01:0.01 |
| Compatibility ratio 3 | 0.3:0.4:0.3 |
| Compatibility ratio 4 | 0.4:0.4:0.2 |
| Compatibility ratio 5 | 0.01:0.01:0.98 |
| Compatibility ratio 6 | 0.6:0.2:0.2 |
| Compatibility ratio 7 | 0.2:0.2:0.6 |
| Compatibility ratio 8 | 0.3:0.2:0.5 |
| Compatibility ratio 9 | 0.2:0.1:0.7 |
| Proportion of compatibility 10 | 0.6:0.1:0.3 |
| Proportion of compatibility 11 | 0.01:0.98:0.01 |
Referring to fig. 1, on the premise of controlling the total amount of the whitening composition derived from the three traditional Chinese medicine active ingredients to be fixed, the effect activity change is associated by the change of the compatibility proportion of each component in the whitening composition derived from the three traditional Chinese medicine active ingredients by using a D-optimal design mathematical calculation method, and the compatibility proportion and the pharmacodynamic relationship of each component in the whitening composition derived from the three traditional Chinese medicine active ingredients are excavated by constructing a corresponding mathematical model, so that a three-dimensional structure diagram is constructed to predict the optimal compatibility proportion range and the optimal compatibility proportion. In fig. 1, a is the mass ratio of raspberry ketone glucoside; b is pterostilbene mass ratio; c is mass ratio of senkyunolide A. The three components of the whitening composition derived from the three traditional Chinese medicine active ingredients are subjected to coordination compatibility design from the digital-analog angle, and the optimal melanogenesis inhibition effect is achieved when the compatibility proportion of raspberry ketone glucoside, pterostilbene and senkyunolide A=0.54:0.25:0.21 is predicted.
And then carrying out biological evaluation on the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios from the cell and zebra fish level, and verifying the whitening effect of the whitening composition derived from the three traditional Chinese medicine active ingredients with the optimal compatibility ratio.
1. Effect of whitening composition derived from three Chinese medicinal active ingredients with different compatibility ratios on melanogenesis in B16F10 melanocytes
Referring to FIG. 2, B16F10 cells in good exponential growth phase were taken, digested, counted, and inoculated in 10cm cell culture dishes at a concentration of about 1X 10 5 The inoculation amount is 10 mL/dish, and the inoculation amount is placed at 37 ℃ and 5% CO 2 Culturing in an incubator for 24 hours; adding whitening composition derived from three traditional Chinese medicine active ingredients with different compatibility ratios, and culturing for 72h; collecting the cells after the administration treatment, adding 100 mu L of non-denaturing lysis solution (containing 1mM PMSF), and lysing at 4 ℃ for 20min; centrifuging at 12000r/min for 10min at 4deg.C to obtain melanin precipitate at the bottom of the centrifuge tube. 330. Mu.L NaOH (10% DMSO) was added, vortexed to facilitate sufficient lysis, and placed in a metal bath at 80℃for 2h to allow sufficient dissolution of the melanin precipitate. Vortex mixing, adding 100 μl of melanin solution into each well of 96-well plate, setting 3 multiple wells, and measuring OD value at 405 nm.
The effect of the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios on the melanogenesis in the B16F10 melanocyte is shown in fig. 2, and compared with the blank control group, the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios has different degrees of inhibition effects on the melanogenesis in the B16F10 melanocyte, wherein the optimal compatibility ratio group has the best inhibition effect (0.01, 0.001).
The experimental results show that: compared with a blank control group, the whitening composition derived from three traditional Chinese medicine active ingredients with different compatibility ratios can obviously inhibit the synthesis of B16F10 cell melanin, and the optimal compatibility ratio group, namely, the raspberry ketone glucoside, namely, pterostilbene, senkyunolide A=0.54:0.25:0.21 has obviously better effect on inhibiting the melanin in B16F10 cell than other compatibility ratio groups.
2. Effect of whitening composition derived from three Chinese medicinal active ingredients with different compatibility ratios on B16F10 melanocyte tyrosinase activity
Referring to FIG. 3, B16F10 cells in good exponential growth phase were taken, digested, counted, and inoculated in 10cm cell culture dishes at a concentration of about 1X 10 5 The inoculation amount is 10 mL/dish, and the inoculation amount is placed at 37 ℃ and 5% CO 2 Culturing in an incubator for 24 hours; adding whitening composition derived from three traditional Chinese medicine active ingredients with different compatibility ratios, and culturing for 72h; collecting the cells after the administration treatment, adding 100 mu L of non-denaturing lysis solution (containing 1mM PMSF), and lysing at 4 ℃ for 20min; centrifuging at 4deg.C and 12000r/min for 10min, and collecting supernatant as total cell protein extractive solution. After extraction of cellular proteins, 10. Mu.g of the total protein amount of the cell lysis supernatant was added to a centrifuge tube, and the supernatant was supplemented to 100. Mu.L with PBS (pH 6.8), and after sufficient mixing, 96-well plates were added, and then 0.1% L-DOPA was added to 100. Mu.L, 3 wells were set for each group, and incubated at 37℃for 1 hour in the absence of light. Absorbance values were determined at 475 nm. The higher absorbance value indicates higher tyrosinase activity.
The effect of the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios on the tyrosinase activity of the B16F10 melanocyte is shown in fig. 3, and compared with the blank control group, the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios has different degrees of inhibition effects on the tyrosinase activity of the B16F10 melanocyte, wherein the best compatibility ratio group has the best inhibition effect (less than 0.05, less than 0.01, less than 0.001).
Experimental results: compared with a blank control group, the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios can obviously inhibit the activity of B16F10 cell tyrosinase, and the optimal compatibility ratio group, namely, the raspberry ketone glucoside, namely, pterostilbene, and senkyunolide A=0.54:0.25:0.21 have obviously better inhibition effect on the activity of B16F10 cell tyrosinase than other compatibility ratio groups.
3. Effect of whitening composition derived from three Chinese medicinal active ingredients with different compatibility ratios on synthesis of zebra fish melanin
Referring to fig. 4, the experimental procedure used AB-line wild-type zebra fish. The zebra fish breeding method is carried out according to The zebrafish book. The water temperature for feeding is kept at about 28.5 ℃, the light is applied for 14 hours and the dark is applied for 10 hours each day, and the feed is fed once in the morning and evening. The day before embryo collection, 1 female fish and 2 male fish were placed in spawning jars and separated by a baffle and placed in a darkened environment. And (5) in the morning of the next day, the partition board is opened after the lamplight is started, and embryos are collected after spawning is completed. Embryos are placed in an eggwater and incubated in a light incubator at 28.5 ℃.
Collecting embryo at about 7-8hpf, thoroughly changing liquid to clean embryo, removing embryo in bad state, transferring to 6-well plate, placing 20 embryo in each hole, and adding whitening composition derived from three traditional Chinese medicine active ingredients with different compatibility ratio; when the strain is cultured to 54hpf in a light incubator at 28.5 ℃, the embryo state and melanin change of the zebra fish are observed, and a picture is taken by a split microscope. The effect of the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios on the synthesis of the zebra fish melanin is shown in figure 4.
The experimental results show that: compared with a blank control group, the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios can obviously inhibit the synthesis of the zebra fish melanin. And the optimal compatibility proportion group, namely, the inhibition effect on the generation of the black pigment of the zebra fish is obviously better than that of other compatibility proportion groups when the raspberry ketone glucoside is pterostilbene and senkyunolide A=0.54:0.25:0.21.
The biological evaluation of the whitening composition derived from the three traditional Chinese medicine active ingredients with different compatibility ratios from the cell and zebra fish level can confirm that the inhibition effect of the whitening composition derived from the three traditional Chinese medicine active ingredients on melanin and tyrosinase activity in B16F10 cells, which is formed by the three components, is obviously superior to other compatibility ratio groups, and the inhibition effect of the whitening composition derived from the three traditional Chinese medicine active ingredients on melanin of zebra fish is obviously superior to other compatibility ratio groups when pterostilbene and senkyunolide A=0.54:0.25:0.21. According to the technical scheme of the whitening composition derived from three traditional Chinese medicine active ingredients and the application thereof, the three traditional Chinese medicine active ingredients are utilized, and the whitening composition derived from the three traditional Chinese medicine active ingredients can be used in the fields of medicines and cosmetics, has good whitening effect by inhibiting tyrosinase activity, reducing tyrosinase expression level, scavenging free radicals, scavenging NO, inhibiting multi-dimensional and multi-path melanin formation such as melanosome transportation and the like, and has high market popularization value.
In conclusion, the whitening composition derived from three traditional Chinese medicine active ingredients and the application thereof provided by the invention have good whitening effect by utilizing the three active ingredients derived from natural traditional Chinese medicines, inhibiting tyrosinase activity, reducing tyrosinase expression level, scavenging free radicals, scavenging NO, inhibiting multi-dimensional and multi-path melanin formation such as melanosome transportation and the like, and the whitening composition derived from three traditional Chinese medicine active ingredients can be used in the fields of medicines and cosmetics and has high market popularization value.
It will be appreciated by persons skilled in the art that the above embodiments are provided for illustration only and not for limitation of the invention, and that variations and modifications of the above described embodiments are intended to fall within the scope of the claims of the invention as long as they fall within the true spirit of the invention.
Claims (5)
1. The whitening composition is characterized by comprising, by weight, 24-82 parts of raspberry ketone glucoside, 16-41 parts of pterostilbene and 11-36 parts of senkyunolide A.
2. The whitening composition derived from three traditional Chinese medicine active ingredients according to claim 1, wherein the mass ratio of raspberry ketone glucoside, pterostilbene and senkyunolide A is preferably 0.54:0.25:0.21.
3. The whitening composition derived from three traditional Chinese medicine active ingredients according to claim 1, wherein the raspberry ketone glucoside, pterostilbene and senkyunolide A are prepared by chemical synthesis or natural animal and plant extraction and purification.
4. Use of a whitening composition derived from three traditional Chinese medicine active ingredients according to any one of claims 1 to 3 in a medicament or cosmetic for the treatment and/or prevention of hyperchromic diseases.
5. The use of a whitening composition derived from three chinese medicinal active ingredients according to claim 4, wherein the pigmentary disorders include freckle, chloasma, senile plaque, cyasma, coffee, sunburn, nevus and melanoma-associated skin diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310317833.XA CN116236408B (en) | 2023-03-29 | 2023-03-29 | Whitening composition derived from three traditional Chinese medicine active ingredients and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310317833.XA CN116236408B (en) | 2023-03-29 | 2023-03-29 | Whitening composition derived from three traditional Chinese medicine active ingredients and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN116236408A true CN116236408A (en) | 2023-06-09 |
| CN116236408B CN116236408B (en) | 2024-05-24 |
Family
ID=86633305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310317833.XA Active CN116236408B (en) | 2023-03-29 | 2023-03-29 | Whitening composition derived from three traditional Chinese medicine active ingredients and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116236408B (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040081631A1 (en) * | 2002-10-29 | 2004-04-29 | Kang-Tae Lee | Cosmetic composition for skin whitening comprising senkyunolide a as active ingredient |
| KR100681700B1 (en) * | 2005-12-28 | 2007-02-15 | 주식회사 코리아나화장품 | Cosmetic composition for skin whitening comprising senkyunolide a and gluconic acid as active ingredients |
| CN112451400A (en) * | 2020-11-28 | 2021-03-09 | 广州梦姿科技有限公司 | Water-in-oil type multi-effect whitening face cream |
| CN112545963A (en) * | 2020-12-30 | 2021-03-26 | 上海澄穆化妆品有限公司 | Composition with whitening effect, whitening compound preparation and preparation method of whitening compound preparation |
-
2023
- 2023-03-29 CN CN202310317833.XA patent/CN116236408B/en active Active
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040081631A1 (en) * | 2002-10-29 | 2004-04-29 | Kang-Tae Lee | Cosmetic composition for skin whitening comprising senkyunolide a as active ingredient |
| KR100681700B1 (en) * | 2005-12-28 | 2007-02-15 | 주식회사 코리아나화장품 | Cosmetic composition for skin whitening comprising senkyunolide a and gluconic acid as active ingredients |
| CN112451400A (en) * | 2020-11-28 | 2021-03-09 | 广州梦姿科技有限公司 | Water-in-oil type multi-effect whitening face cream |
| CN112545963A (en) * | 2020-12-30 | 2021-03-26 | 上海澄穆化妆品有限公司 | Composition with whitening effect, whitening compound preparation and preparation method of whitening compound preparation |
Non-Patent Citations (1)
| Title |
|---|
| 彭冠杰 等: "美白化妆品的功效评价", 日用化学品科学, vol. 42, no. 12, pages 56 - 60 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN116236408B (en) | 2024-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103284940B (en) | Saccharomycetes fermented traditional Chinese medicine composition, as well as preparation method and application thereof | |
| CN101102746B (en) | Skin-condition improving composition comprising vaccinium uliginosum extract and method for preparation thereof | |
| US9079047B2 (en) | Cosmetic composition for skin whitening | |
| WO2012070835A2 (en) | Cosmetic composition containing gulfweed extract, sea staghorn extract, and brown seaweed extract | |
| KR101111533B1 (en) | Whitening cosmetic composition containing the extract of puer tea, black garlic and Moutan Radicis Cortex | |
| CN108697706B (en) | Melanin decomposition inhibitor | |
| CN116236408B (en) | Whitening composition derived from three traditional Chinese medicine active ingredients and application thereof | |
| KR101946526B1 (en) | Composition of preventing or improving UV-induced skin damage comprising hydrangenol | |
| CN113476321A (en) | Application of isosteviol in preparing cosmetic preparation for whitening skin and resisting melanin generation | |
| Namjoyan et al. | The anti-melanogenesis activities of some selected red macroalgae from northern coasts of the Persian Gulf | |
| CN104152401A (en) | CHMM1 culture medium suitable for in-vitro culture of Chinese epidermal melanocytes | |
| WO2010120150A2 (en) | Cosmetic material composition | |
| CN113749260A (en) | Collagen peptide composition and preparation method thereof | |
| KR101135264B1 (en) | Cosmetic composition containing the extract of medicinal herb mixture | |
| KR101093901B1 (en) | A cosmetic composition comprising an extract of tissue cultured anoectochilus formosanus and a preparation method of the extract of tissue cultured anoectochilus formosanus | |
| KR20150000719A (en) | Cosmetic Composition Comprising Persicaria thunbergii Extract for Skin Whitening | |
| US20210196677A1 (en) | Method of preventing or improving uv-induced skin damage using hydroangenol as active ingredient | |
| KR102224313B1 (en) | Composition for skin whitening comprising scutellaria alpina extract | |
| KR20090050856A (en) | Skin whitening cosmetic composition containing fraction extract of cimicifuga heracleifolia extracts, manufacturing method thereof | |
| KR20080032274A (en) | The manufacturing process of an antiaging soap | |
| KR20210006090A (en) | Pharmaceutical composition for preventing or treating vitiligo or canities comprising extract of Melia azedarach extract as an active ingredient | |
| KR20020076775A (en) | Skin whitening cosmetic formulations co-containing melanogenesis inhibitors and UV B irradiation- induced prostaglandin synthesis inhibitors in skin cells | |
| KR101278071B1 (en) | Cosmetic composition containing Betula costata extract | |
| KR102683218B1 (en) | Composition for whitening comprising natural products derived extracellular vesicles | |
| KR20050022315A (en) | Use of a Rhodiola crenulata extract via the topical route |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |